These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3673134)

  • 21. [Value of Holter's dynamic ECG a as predictor of the effectiveness of anti-arrhythmia therapy].
    Sanna GP
    G Ital Cardiol; 1986 Aug; 16(8):663-6. PubMed ID: 3792732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Arrhythmogenic effect of anti-arrhythmia drugs].
    Trusz-Gluza M
    Kardiol Pol; 1991; 34(1):41-8. PubMed ID: 2051713
    [No Abstract]   [Full Text] [Related]  

  • 23. [Failure of antiarrhythmia agents and understanding the phenomenon of proarrhythmia].
    Semrád B
    Vnitr Lek; 2003 Sep; 49(9):700-6. PubMed ID: 14584417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propafenone for the treatment of severe ventricular arrhythmias.
    Rabkin SW; Rotem CE; Boroomand-Rashti K; Bar-Shlomo B
    Can Med Assoc J; 1984 Sep; 131(6):601-3. PubMed ID: 6478345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Assessment of anti-arrhythmic efficacy of a domestic drug allapinin in patients with ischemic heart disease and cardiac arrhythmia].
    Zamotaev IuN; Kremnev IuA; Grinenko NA; Podshibiakin SE
    Klin Med (Mosk); 2003; 81(11):51-4. PubMed ID: 14689712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Torsade-de-pointes in a patient under flecainide treatment, an unusual case of proarrhythmicity.
    Nogales Asensio JM; Moreno Sánchez N; Doncel Vecino LJ; Villar Mariscal C; López-Mínguez JR; Merchán Herrera A
    Int J Cardiol; 2007 Jan; 114(2):E65-7. PubMed ID: 17056139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF; Coumel P
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The principles of pharmacotherapy for arrhythmia at the turn of the millenium].
    Fazekas T; Liszkai G
    Orv Hetil; 1999 Dec; 140(51):2851-9. PubMed ID: 10647274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The arrhythmogenic effects of antiarrhythmic drugs.
    Julian ID
    Eur Heart J; 1988 Feb; 9 Suppl B():1-4. PubMed ID: 3286261
    [No Abstract]   [Full Text] [Related]  

  • 30. [Proarrhythmic effects of anti-arrhythmia agents].
    Enrico JF; Kehtari R
    Rev Med Suisse Romande; 1998 Aug; 118(8):671-90. PubMed ID: 9838826
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of tocainide and prajmalium bitartrate for the treatment of ventricular arrhythmias.
    Schwartzkopff B; Schilling G; Simon H
    Arzneimittelforschung; 1983; 33(1):153-8. PubMed ID: 6403021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-arrhythmia and arrhythmogenic actions of digoxin in ventricular rhythm disorders in patients with circulatory insufficiency].
    Vangeli RS; Naumov VG; Blank ML; Sergakova LM; Grigoriants RA
    Ter Arkh; 1987; 59(9):81-6. PubMed ID: 3424196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Harmful interactions of amiodarone and class I anti-arrhythmia agents].
    Tartini R; Kappenberger L; Steinbrunn W
    Schweiz Med Wochenschr; 1982 Nov; 112(45):1585-7. PubMed ID: 7156952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inflammation of the myocardium as an arrhythmia trigger].
    Klein RM; Vester EG; Brehm MU; Dees H; Picard F; Niederacher D; Beckmann MW; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():24-35. PubMed ID: 10810782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The efficacy of anti-arrhythmia therapy with bonnecor in middle-aged and elderly patients].
    Zaslavskaia RM; Mirskiĭ BA; Diagilev II
    Klin Med (Mosk); 1996; 74(2):30-2. PubMed ID: 8772098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proarrhythmic actions of antiarrhythmic drugs: a review.
    Campbell TJ
    Aust N Z J Med; 1990 Jun; 20(3):275-82. PubMed ID: 2196873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of ambulatory ECG in a cardiology department].
    Pesola A; Magini G
    G Ital Cardiol; 1987 Dec; 17(12):1055-62. PubMed ID: 3503801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of determination of QT dispersal intervals in anti-arrhythmia therapy].
    Konecná P; Dvorák R; Semrád B
    Vnitr Lek; 1999 Aug; 45(8):453-6. PubMed ID: 11045143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arrhythmogenic effects of antiarrhythmic drugs.
    Maggioni AP; Cavalli A; Latini R; Tognoni G; Volpi A
    Adverse Drug React Acute Poisoning Rev; 1986; 5(4):203-14. PubMed ID: 3548269
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anti-arrhythmia agents. Effectiveness, lack of effectiveness and pro-arrhythmia effects].
    Steinbeck G
    Internist (Berl); 1992 Oct; 33(10):663-9. PubMed ID: 1385349
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.